Tower Research Capital (TRC)’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,069
| Closed | -$60K | – | 6625 |
|
|
2023
Q1 | $60K | Buy |
6,069
+2,574
| +74% | +$25.5K | ﹤0.01% | 2342 |
|
|
2022
Q4 | $35K | Buy |
3,495
+3,231
| +1,224% | +$24.1K | ﹤0.01% | 2625 |
|
|
2022
Q3 | $1K | Sell |
264
-8,386
| -97% | -$46.5K | ﹤0.01% | 5944 |
|
|
2022
Q2 | $32K | Buy |
8,650
+8,579
| +12,083% | +$40.6K | ﹤0.01% | 3321 |
|
|
2022
Q1 | $0 | Buy |
+71
| New | +$433 | ﹤0.01% | 6911 |
|
|
2021
Q4 | – | Sell |
-418
| Closed | -$4K | – | 6825 |
|
|
2021
Q3 | $4K | Sell |
418
-2,308
| -85% | -$19.8K | ﹤0.01% | 5037 |
|
|
2021
Q2 | $22K | Sell |
2,726
-46,028
| -94% | -$316K | ﹤0.01% | 3825 |
|
|
2021
Q1 | $269K | Buy |
48,754
+37,694
| +341% | +$186K | ﹤0.01% | 1758 |
|
|
2020
Q4 | $37K | Buy |
+11,060
| New | +$29.1K | ﹤0.01% | 3408 |
|
|
2020
Q3 | – | Sell |
-7,105
| Closed | -$11K | – | 5212 |
|
|
2020
Q2 | $11K | Buy |
7,105
+6,939
| +4,180% | +$13.8K | ﹤0.01% | 3986 |
|
|
2020
Q1 | $0 | Hold |
166
| – | – | ﹤0.01% | 4183 |
|
|
2019
Q4 | $0 | Buy |
166
+66
| +66% | +$191 | ﹤0.01% | 4624 |
|
|
2019
Q3 | $0 | Sell |
100
-503
| -83% | -$1.59K | ﹤0.01% | 4664 |
|
|
2019
Q2 | $2K | Buy |
+603
| New | +$2.15K | ﹤0.01% | 3350 |
|
|
2019
Q1 | – | Sell |
-1,033
| Closed | -$4K | – | 4468 |
|
|
2018
Q4 | $4K | Buy |
1,033
+486
| +89% | +$2.4K | ﹤0.01% | 3097 |
|
|
2018
Q3 | $4K | Sell |
547
-656
| -55% | -$5.09K | ﹤0.01% | 3241 |
|
|
2018
Q2 | $9K | Buy |
1,203
+1,100
| +1,068% | +$6.84K | ﹤0.01% | 2847 |
|
|
2018
Q1 | $1K | Sell |
103
-5,054
| -98% | -$31.8K | ﹤0.01% | 3124 |
|
|
2017
Q4 | $29K | Buy |
+5,157
| New | +$23.5K | ﹤0.01% | 1772 |
|
|
2017
Q2 | – | Sell |
-39
| Closed | – | – | 3650 |
|
|
2017
Q1 | $0 | Buy |
+39
| New | +$496 | ﹤0.01% | 4141 |
|
|
2016
Q3 | – | Sell |
-18
| Closed | – | – | 4694 |
|
|
2016
Q2 | $0 | Buy |
+18
| New | +$270 | ﹤0.01% | 5157 |
|
|
2014
Q3 | – | Sell |
-5
| Closed | -$1K | – | 5017 |
|
|
2014
Q2 | $1K | Buy |
+5
| New | +$1.59K | ﹤0.01% | 3797 |
|
|
2014
Q1 | – | Sell |
-21
| Closed | -$7K | – | 5082 |
|
|
2013
Q4 | $7K | Buy |
21
+19
| +950% | +$6.98K | ﹤0.01% | 3325 |
|
|
2013
Q3 | $1K | Buy |
2
+1
| +100% | +$438 | ﹤0.01% | 4373 |
|
|
2013
Q2 | $0 | Buy |
+1
| New | +$376 | ﹤0.01% | 3995 |
|
Tower Research Capital (TRC)'s APEN Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 6,069 shares — an estimated $60K sold.
Tower Research Capital (TRC) first reported a position in APEN in Q2 2013 and held it in 25 quarters. The position peaked at $269K in Q1 2021. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 6,069 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $60K.
- Tower Research Capital (TRC) first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 25 quarters.
- Tower Research Capital (TRC)'s Apollo Endosurgery, Inc. position peaked at $269K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.